Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases. (2019)
Attributed to:
MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches (MASTERPLANS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/art.40937
PubMed Identifier: 31131994
Publication URI: http://europepmc.org/abstract/MED/31131994
Type: Journal Article/Review
Volume: 71
Parent Publication: Arthritis & rheumatology (Hoboken, N.J.)
Issue: 11
ISSN: 2326-5191